US Stock MarketDetailed Quotes

PBH Prestige Consumer Healthcare

Watchlist
  • 68.350
  • +0.320+0.47%
Close Apr 18 16:00 ET
3.39BMarket Cap-42718P/E (TTM)

About Prestige Consumer Healthcare Company

Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. It operates through the following segments: North American OTC Healthcare and International OTC Healthcare. The North American and International OTC Healthcare segments manages the following brands: BC/Goody's, Beano, Boudreaux's Butt Paste, Chloraseptic, Clear Eyes, Compound W, Debrox, DenTek, Dramamine, Efferdent, Fess, Fleet, Gaviscon, Hydralyte, Luden's, Monistat, Nix, Pedia-Lax, and Summer's Eve. The company was founded in 1996 and is headquartered in Tarrytown, NY.

Company Profile

SymbolPBH
Company NamePrestige Consumer Healthcare
Listing DateFeb 10, 2005
Issue Price16.00
Founded1996
CEOMr. Ronald M. Lombardi
MarketNYSE
Employees560
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address660 White Plains Road,Suite 250
CityTarrytown
ProvinceNew York
CountryUnited States of America
Zip Code10591
Phone1-914-524-6800

Company Executives

  • Name
  • Position
  • Salary
  • Ronald M. Lombardi
  • Chairman of the Board, President and Chief Executive Officer
  • 5.58M
  • Christine Sacco
  • Chief Financial Officer and Principal Accounting Officer
  • 1.96M
  • William C. P'Pool
  • Senior Vice President, General Counsel and Corporate Secretary
  • 1.29M
  • Jeffrey Zerillo
  • Executive Vice President, Operations
  • 846.92K
  • Adel Mekhail
  • Executive Vice President, Marketing and Sales
  • 1.30M
  • Sheila A. Hopkins
  • Independent Director
  • 240.00K
  • Natale S. Ricciardi
  • Independent Director
  • 240.00K
  • Dr. Celeste A. Clark, PhD
  • Independent Director
  • 257.01K
  • Dawn M. Zier
  • Independent Director
  • 257.50K
  • James C. D’Arecca
  • Independent Director
  • --
  • Christopher J. Coughlin
  • Independent Director
  • 260.00K
  • John E. Byom
  • Lead Independent Director
  • 270.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg